Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Monge-Argilés, J.A.
28  Ergebnisse:
Personensuche X
?
1

Diagnostic Validity Comparison Between Criteria Based on CS..:

Blanco-Cantó, Maria Empar ; Monge-Argilés, J. A. ; Pérez-Cejuela, C....
American Journal of Alzheimer's Disease & Other Dementiasr.  32 (2017)  2 - p. 101-107 , 2017
Link: https://doi.org/10.1177/..
 
?
2

Influence of APOE Genotype on Alzheimer's Disease CSF Bioma..:

Monge-Argilés, J. A. ; Gasparini-Berenguer, R. ; Gutierrez-Agulló, M....
BioMed Research International.  2016 (2016)  - p. 1-7 , 2016
Link: https://doi.org/10.1155/..
 
?
3

Diagnostic validity comparison between NIA criteria for CSF..:

Monge-Argilés, J.A. ; Blanco-Cantó, M.E. ; García-Pérez, C....
Journal of the Neurological Sciences.  333 (2013)  - p. e311 , 2013
Link: https://doi.org/10.1016/..
 
?
4

CSF Alzheimer'/INS;s disease biomarker /INS;validity for ea..:

Monge-Argilés, J.A. ; Blanco-Cantó, M.E. ; García-Pérez, C....
Journal of the Neurological Sciences.  333 (2013)  - p. e312 , 2013
Link: https://doi.org/10.1016/..
 
?
5

Alzheimer'/INS;s disease CSF biomarkers predict cognitive d..:

Monge-Argilés, J.A. ; Gasparini-Berenguer, R. ; Muñoz-Ruiz, C....
Journal of the Neurological Sciences.  333 (2013)  - p. e301-e302 , 2013
Link: https://doi.org/10.1016/..
 
?
6

Biomarkers of Alzheimer′s Disease in the Cerebrospinal Flui..:

Monge-Argilés, J. A. ; Muñoz-Ruiz, C. ; Pampliega-Pérez, A....
Neurochemical Research.  36 (2011)  6 - p. 986-993 , 2011
Link: https://doi.org/10.1007/..
 
?
7

Do CSF biomarkers help clinicians predict the progression o..:

Mitchell, Alex J ; Monge-Argilés, J A ; Sánchez-Paya, J
Practical Neurology.  10 (2010)  4 - p. 202-207 , 2010
Link: https://doi.org/10.1136/..
 
?
8

Heart rate variability in multiple sclerosis during a stabl..:

Monge-Argilés, J. A. ; Palacios-Ortega, F. ; Vila-Sobrino, J. A..
Acta Neurologica Scandinavica.  97 (2009)  2 - p. 86-92 , 2009
Link: https://doi.org/10.1111/..
 
?
9

Validity of CSF alpha-synuclein to predict psychosis in pro..:

Monge-García, Sonia ; García-Ayllón, María-Salud ; Sánchez-Payá, José...
Frontiers in Neurology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
10

Relation between Alpha-Synuclein and Core CSF Biomarkers of..:

Monge-García, Victoria ; García-Ayllón, María-Salud ; Sáez-Valero, Javier...
Medicina.  57 (2021)  9 - p. 954 , 2021
Link: https://doi.org/10.3390/..
 
?
11

Use of Antipsychotics in Patients with Behavioral and Psych..:

Manzano-Palomo, Sagrario ; Agüera-Ortiz, Luis F. ; García-Caballero, Alexandre...
Dementia and Geriatric Cognitive Disorders.  49 (2020)  6 - p. 573-582 , 2020
Link: https://doi.org/10.1159/..
 
?
12

P3‐240: Biomarkers of Alzheimer's disease in CSF of patient..:

Monge-Argilés, Antonio ; Muñoz-Ruiz, Carlos ; Pampliega-Perez, Ana...
Alzheimer's & Dementia.  6 (2010)  4S_Part_17 - p. , 2010
Link: https://doi.org/10.1016/..
 
?
13

Comparison of Two Analytical Platforms for CSF Biomarkers o..:

Monge-Argilés, Jose Antonio ; Muñoz-Ruiz, Carlos ; Sánchez-Payá, José...
BioMed Research International.  2014 (2014)  - p. 1-5 , 2014
Link: https://doi.org/10.1155/..
 
?
14

Influence of APOE Genotype on Alzheimer's Disease CSF Bioma..:

J. A. Monge-Argilés ; R. Gasparini-Berenguer ; M. Gutierrez-Agulló...
http://dx.doi.org/10.1155/2016/1390620.  , 2016
Link: https://doi.org/10.1155/..
 
?
15

Patients with mild cognitive impairment and a reduced CSF A..:

J.A. Monge-Argilés ; J. Sánchez-Payá ; C. Muñoz-Ruiz...
http://www.sciencedirect.com/science/article/pii/S2173580812000119.  , 2012
Link: https://doi.org/10.1016/..
 
1-15